CPB
55
-10
MSFT
46
3
KMX
50
2
AIZ
71
2
AMAT
43
3
BF.B
48
8
EOG
45
2
UPS
56
6
NSC
70
5
PNW
69
5
ROST
60
3
R
56
6
RIG
22
2
AFL
59
2
COST
56
8
SNA
55
5
GWW
60
9
WBA
21
2
DGX
43
12
DLTR
34
12
CPB
55
-10
MSFT
46
3
KMX
50
2
AIZ
71
2
AMAT
43
3
BF.B
48
8
EOG
45
2
UPS
56
6
NSC
70
5
PNW
69
5
ROST
60
3
R
56
6
RIG
22
2
AFL
59
2
COST
56
8
SNA
55
5
GWW
60
9
WBA
21
2
DGX
43
12
DLTR
34
12
Financhill
Back

Corbus Pharmaceuticals Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Sell
49

CRBP
Corbus Pharmaceuticals Holdings

Last Price:
52.68
Seasonality Move:
-9.84%
Sell
49

CATX
Perspective Therapeutics

Last Price:
15.63
Seasonality Move:
-11.56%
Sell
49
Corbus Pharmaceuticals Holdings (CRBP) is a Sell

Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?

  • The current Corbus Pharmaceuticals Holdings [CRBP] share price is $52.70. The Score for CRBP is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CRBP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $15.61. The Score for CATX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CRBP Stock Price Chart

What is Corbus Pharmaceuticals Holdings's stock price today?

  • The Corbus Pharmaceuticals Holdings share price today is $52.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $15.61
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing slight selling pressure.

CRBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 45.7 Sell
Chaikin Money Flow: 18197 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.98 - 58.8) Sell
Bollinger Bands (100): (41.39 - 56.37) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.66 Buy
Relative Strength Index (14 RSI): 59.53 Buy
Chaikin Money Flow: -16124 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.74 - 15.58) Buy
Bollinger Bands (100): (11.57 - 16.09) Buy

CRBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.95 Sell
20-day SMA: 55.91 Sell
50-day SMA: 55.14 Sell
200-day SMA: 35.07 Buy
8-day EMA: 54.13 Sell
20-day EMA: 55.36 Sell
50-day EMA: 53.82 Sell
200-day EMA: 38.8 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.26 Buy
20-day SMA: 14.69 Buy
50-day SMA: 13.15 Buy
200-day SMA: 10.79 Buy
8-day EMA: 15.25 Buy
20-day EMA: 14.69 Buy
50-day EMA: 13.8 Buy
200-day EMA: 11.26 Buy

Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.12 per share, an increase next quarter of $0.03 per share, an increase this year of $7.24 per share, and a decrease next year of $0.09 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.08 per share.

Corbus Pharmaceuticals Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):